Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -42.00% | -31.53% | -24.63% | -13.19% | -17.11% |
| Total Receivables | -9.53% | 17.84% | 5.52% | -54.17% | 89.05% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -15.09% | -1.47% | -10.99% | 56.19% | 8.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -36.58% | -26.59% | -22.49% | -15.54% | -11.90% |
|
|
|||||
| Total Current Assets | -36.58% | -26.59% | -22.49% | -15.54% | -11.90% |
| Net Property, Plant & Equipment | -13.98% | -12.88% | -17.20% | -5.88% | -9.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -3.43% | -0.57% | -4.09% | 1.38% | -1.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -36.28% | -26.43% | -22.42% | -15.45% | -11.87% |
|
|
|||||
| Total Accounts Payable | 12.28% | 18.47% | 12.02% | 24.35% | 43.82% |
| Total Accrued Expenses | 7.43% | -31.57% | -44.58% | -17.00% | 34.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.48% | 6.52% | 4.71% | 24.63% | 22.66% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.58% | 9.88% | -4.50% | 8.65% | 39.87% |
|
|
|||||
| Total Current Liabilities | 11.58% | 9.88% | -4.50% | 8.65% | 39.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -24.07% | -18.24% | -18.09% | -7.85% | -11.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -77.24% | -38.79% | -7.76% | -23.11% | -58.73% |
| Total Liabilities | -14.19% | -10.74% | -6.06% | -7.75% | -37.13% |
|
|
|||||
| Common Stock & APIC | -1.24% | 1.83% | -1.75% | 13.88% | 0.49% |
| Retained Earnings | -1.62% | -5.05% | -1.80% | -9.78% | 0.89% |
| Treasury Stock & Other | 188.07% | 7.65% | 42.41% | -99.62% | -0.29% |
| Total Common Equity | -60.65% | -38.39% | -31.50% | -19.19% | 9.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -60.65% | -38.39% | -31.50% | -19.19% | 9.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -60.65% | -38.39% | -31.50% | -19.19% | 9.53% |
|
|
|||||